Quick Takeaways
- Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for C4 Therapeutics, Inc Common Stock, par value $0.0001 per share (CCCC).
- Disclosed ownership: 10%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"Soleus Capital Master Fund, L.P. disclosed 10% ownership in C4 Therapeutics, Inc Common Stock, par value $0.0001 per share (CCCC) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Private Equity Fund III, L.P. | 5.9% | 6,072,822 | 0 | 6,072,822 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Private Equity GP III, LLC | 5.9% | 6,072,822 | 0 | 6,072,822 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus PE GP III, LLC | 5.9% | 6,072,822 | 0 | 6,072,822 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Master Fund, L.P. | 10% | 10,361,860 | 0 | 10,361,860 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital, LLC | 10% | 10,361,860 | 0 | 10,361,860 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Group, LLC | 10% | 10,361,860 | 0 | 10,361,860 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Management, L.P. | 10% | 10,334,114 | 0 | 10,334,114 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus GP, LLC | 10% | 10,334,114 | 0 | 10,334,114 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Guy Levy | 10% | 10,334,114 | 0 | 10,334,114 | /s/ Guy Levy | Guy Levy |